Serum ferritin and vitamin D levels should be evaluated in patients with diffuse hair loss prior to treatment

dc.contributor.authorTamer, Funda
dc.contributor.authorYüksel, Mehmet Eren
dc.contributor.authorKaraba?, Yavuz
dc.date.accessioned2021-02-04T07:01:21Z
dc.date.available2021-02-04T07:01:21Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.descriptionYüksel, Mehmet Eren ( Aksaray, Yazar )
dc.description.abstractIntroduction: Various factors like physiological and emotional stress, drugs and nutritional deficiencies can result in hair loss. Results of laboratory tests examining the underlying aetiology of hair loss vary in patients. Aim: We aimed to compare the serum levels of ferritin, folate, vitamin B12, zinc, thyroid stimulating hormone and vitamin D in patients complaining of diffuse hair loss and in healthy individuals. Material and methods: Fifty-four patients with hair loss (47 females, 7 males) and 55 healthy individuals within the control group (47 females, 8 males) were included in this study. Serum levels of ferritin, folate, vitamin B12, zinc, thyroid stimulating hormone and 25-hydroxyvitamin D were evaluated in all participants retrospectively. Results: Serum concentrations of folate, vitamin B12, zinc and thyroid stimulating hormone were similar in the two groups. However, the mean serum ferritin and 25-hydroxyvitamin D levels were significantly lower in patients with hair loss than in healthy individuals. The mean serum ferritin levels of the patients and healthy individuals were 14.72 10.70 ng/ml and 25.30 14.41 ng/ml, respectively. The mean serum 25-hydroxyvitamin D levels of the patients and healthy individuals were 14.03 8.09 ng/ml and 17.01 8.59 ng/ml, respectively. Eleven (20.4%) patients had low serum ferritin levels, while 43 (79.6%) patients had low vitamin D levels. Conclusions: The results obtained from this study reveal that serum ferritin and 25-hydroxyvitamin D levels are generally low in patients complaining of hair loss. Therefore, serum ferritin and vitamin D levels should be evaluated and supplemented prior to treatment in all patients complaining of diffuse hair loss.
dc.identifier.doi10.5114/ada.2020.96251
dc.identifier.endpage411en_US
dc.identifier.issn1642-395X
dc.identifier.issue3en_US
dc.identifier.pmid32792884
dc.identifier.scopusqualityQ2
dc.identifier.startpage407en_US
dc.identifier.urihttps:/dx.doi.org/ 10.5114/ada.2020.96251
dc.identifier.urihttps://hdl.handle.net/20.500.12451/7721
dc.identifier.volume37en_US
dc.identifier.wosWOS:000551559000019
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTermedia Publishing House Ltd.
dc.relation.ispartofPostepy Dermatologii i Alergologii
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAlopecia
dc.subjectHair Loss
dc.subjectIron
dc.subjectVitamin D
dc.titleSerum ferritin and vitamin D levels should be evaluated in patients with diffuse hair loss prior to treatment
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
tamer-funda-2020.pdf
Boyut:
134.77 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: